GLP-1RA vs DPP-4i Use and Rates of Hyperkalemia and RAS Blockade Discontinuation in Type 2 Diabetes.
Sign Up to like & getrecommendations! Published in 2024 at "JAMA internal medicine"
DOI: 10.1001/jamainternmed.2024.3806
Abstract: Importance Hyperkalemia is a common complication in people with type 2 diabetes (T2D) that may limit the use of guideline-recommended renin-angiotensin system inhibitors (RASis). Emerging evidence suggests that glucagon-like peptide-1 receptor agonists (GLP-1RAs) increase urinary… read more here.
Keywords: rates hyperkalemia; use; dpp; glp 1ra ... See more keywords